Business Description
PharmaCielo Ltd
NAICS : 325411
SIC : 3741
ISIN : CA00035L1022
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -0.39 | |||||
Debt-to-Equity | -2.75 | |||||
Debt-to-EBITDA | -2.25 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -17.17 | |||||
Beneish M-Score | -21.32 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -25.3 | |||||
3-Year EBITDA Growth Rate | 41.1 | |||||
3-Year EPS without NRI Growth Rate | 41.3 | |||||
3-Year FCF Growth Rate | 49.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.29 | |||||
9-Day RSI | 44.31 | |||||
14-Day RSI | 46.19 | |||||
6-1 Month Momentum % | -48.39 | |||||
12-1 Month Momentum % | -48.39 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.15 | |||||
Quick Ratio | 0.07 | |||||
Days Inventory | 305.35 | |||||
Days Sales Outstanding | 44.72 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.8 | |||||
Shareholder Yield % | -36.84 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 1.23 | |||||
Operating Margin % | -227.61 | |||||
Net Margin % | -540.32 | |||||
FCF Margin % | -118.79 | |||||
ROA % | -63.06 | |||||
ROIC % | -18.52 | |||||
ROC (Joel Greenblatt) % | -57.02 | |||||
ROCE % | -350.91 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.67 | |||||
EV-to-EBIT | -3.4 | |||||
EV-to-EBITDA | -3.88 | |||||
EV-to-Revenue | 13.92 | |||||
EV-to-FCF | -11.44 | |||||
Earnings Yield (Greenblatt) % | -29.41 | |||||
FCF Yield % | -20.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
PharmaCielo Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 2.597 | ||
EPS (TTM) (C$) | -0.09 | ||
Beta | 1.05 | ||
Volatility % | 91 | ||
14-Day RSI | 46.19 | ||
14-Day ATR (C$) | 0.013067 | ||
20-Day SMA (C$) | 0.09825 | ||
12-1 Month Momentum % | -48.39 | ||
52-Week Range (C$) | 0.065 - 0.29 | ||
Shares Outstanding (Mil) | 169.75 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
PharmaCielo Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
PharmaCielo Ltd Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
PharmaCielo Ltd Frequently Asked Questions
What is PharmaCielo Ltd(TSXV:PCLO)'s stock price today?
When is next earnings date of PharmaCielo Ltd(TSXV:PCLO)?
Does PharmaCielo Ltd(TSXV:PCLO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |